Clinical Trial

A Bioequivalence Study of Advil Tablet (Mini) (Ibuprofen 200 mg) Versus Advil Tablet (Ibuprofen 200 mg) in Healthy Adult Subjects Under Fasted Conditions and Bioavailability Assessment of Advil Tablet (Mini) Under Fed Conditions

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the bioequivalence of Advil Tablet (Mini) (Test Product) to Advil Tablet (Reference Product) under fasted conditions and to characterize the impact of food on the bioavailability of the Test Product under fed conditions.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-06.
Status change: Recruiting → Completed 2026-03-12
Trial Details
NCT Number NCT07345130
Lead Sponsor HALEON
Conditions Bioequivalence, Bioavailability
Enrollment 50 participants
Start Date 2025-12-17
Primary Completion 2026-02-03 (estimated)
Study Completion 2026-02-03 (estimated)
Updated on ClinicalTrials.gov 2026-03-13